Spirita Oncology Competitors and Similar CompaniesClear all

Spirita Oncology's competitors and similar companies include CerRx, Agios Pharmaceuticals, TriSalus Life Sciences and Debiopharm.
Spirita Oncology
Spirita Oncology
Spirita Oncology is a drug development company.
CerRx
CerRx
CerRx is an anticancer drug discovery and development company.
Agios Pharmaceuticals
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
TriSalus Life Sciences
TriSalus Life Sciences
TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors.
Debiopharm
Debiopharm
Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections.
Founding Date
Founding Date
N/A
Founding Date
2008
Founding Date
2008
Founding Date
2009
Founding Date
1979
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Natick, US HQ
Locations
Lubbock, US HQ
Locations
Cambridge, US HQ
Locations
Westminster, US HQ
Bannockburn, US
Cranston, US
Locations
Lausanne, CH HQ
Oss, NL
Employees
Employees
N/A
Employees
N/A
Employees
53611% increase
Employees
106
Employees
4771% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2.7 b
Valuation ($)
117.2 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$54m (FY, 2025)
Revenue (est.)
$45.2m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$6.3m (FY, 2025)
Cost of goods
$7m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$47.7m (FY, 2025)
Gross profit
$38.2m (FY, 2025)
Gross profit
N/A
Net income
Net income
N/A
Net income
N/A
Net income
($412.8m) (FY, 2025)
Net income
($39.2m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 2.1m
Total funding raised
N/A
Total funding raised
$ 52.2m
Total funding raised
$ 2.1m
For sources of this data, please see the company profile

View Company Profiles

CerRx
HQ
Lubbock, US

CerRx is an anticancer drug discovery and development company.

View company
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

View company
TriSalus Life Sciences
HQ
Westminster, US
Employees
106

TriSalus Life Sciences (formerly MedTech Acquisition and Surefire Medical) is a company that develops a transformative platform for treating liver and pancreatic tumors.

View company
Debiopharm
HQ
Lausanne, CH
Employees
477↓ 1% decrease

Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections.

View company